Page last updated: 2024-11-06

violapterin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Violapterin is a natural product isolated from the violet species *Viola tricolor*. It exhibits a range of biological activities, including antimicrobial, anti-inflammatory, and antioxidant properties. It is known to inhibit the growth of various bacteria and fungi, and its potential as a therapeutic agent is being explored. Violapterin's complex structure and unique biological activities have made it a target for synthetic studies. Researchers are investigating its synthesis to develop new and potentially more potent analogs with improved pharmacological profiles. The study of violapterin aims to understand its mechanism of action and explore its potential as a drug lead for various diseases. Its anti-inflammatory effects are particularly promising, and research focuses on its ability to modulate inflammatory pathways and suppress inflammatory responses in various disease models.'

2,4,7-trihydroxypteridine : A member of the class of pteridines that is pteridine in which the hydrogens at positions 2, 4, and 7 have been replaced by hydroxy groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID75734
CHEBI ID85515
SCHEMBL ID5443522
MeSH IDM0121370

Synonyms (26)

Synonym
nsc 405591
3h368n1b88 ,
unii-3h368n1b88
2,4,7-pteridinetriol
2,4,7-trihydroxypteridine
isoxantholumazine
lumazine, 7-hydroxy-
nsc405591
2,7(1h,3h,8h)-pteridinetrione
nsc-405591
2577-38-0
2,7-pteridinetriol
2,7-trihydroxypteridine
violapterin
7-hydroxylumazine
1,8-dihydropteridine-2,4,7-trione
2,4,7(1h,3h,8h)-pteridinetrione
SCHEMBL5443522
BCVUYVOMXUKYFC-UHFFFAOYSA-N
pteridine-2,4,7-triol
CHEBI:85515
DTXSID30180440
Q27158614
pteridine-2,4,7(1h,3h,8h)-trione
1,2,3,4,7,8-hexahydropteridine-2,4,7-trione
STARBLD0004690
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
pteridines
heteroaryl hydroxy compoundAny organic aromatic compound having one or more hydroxy groups attached to a heteroarene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (40.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.46

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.46 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.25 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.46)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]